LGND (STOCKS)
Ligand Pharmaceuticals Inc.
$253.250000
-2.290000 (-0.90%)
Prev close: $255.540000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Todd Christopher Davis
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5,090.44M
- Employees
- 68
- P/E (TTM)
- 34.65
- P/B (TTM)
- 5.13
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $274.48M |
| Benefits Costs and Expenses | $89.60M |
| Costs And Expenses | $89.60M |
| Nonoperating Income/Loss | $90.30M |
| Operating Expenses | $179.89M |
| Research and Development | $33.25M |
| Other Operating Expenses | $146.65M |
| Operating Income/Loss | $94.59M |
| Income/Loss From Continuing Operations After Tax | $153.56M |
| Income/Loss From Continuing Operations Before Tax | $184.88M |
| Income Tax Expense/Benefit | $31.32M |
| Net Income/Loss | $153.56M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $153.56M |
| Net Income/Loss Available To Common Stockholders, Basic | $153.56M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $7.90 |
| Diluted Earnings Per Share | $7.43 |
| Basic Average Shares | 58,759,000 |
| Diluted Average Shares | 60,562,000 |
| Assets | $1.53B |
| Current Assets | $865.42M |
| Inventory | $13.27M |
| Other Current Assets | $852.15M |
| Noncurrent Assets | $666.69M |
| Fixed Assets | $3.44M |
| Intangible Assets | $217.34M |
| Other Non-current Assets | $445.91M |
| Liabilities | $534.78M |
| Current Liabilities | $40.67M |
| Accounts Payable | $5.26M |
| Wages | $3.55M |
| Other Current Liabilities | $31.85M |
| Noncurrent Liabilities | $494.12M |
| Equity | $997.32M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $997.32M |
| Liabilities And Equity | $1.53B |
| Net Cash Flow From Operating Activities | $123.50M |
| Net Cash Flow From Operating Activities, Continuing | $123.50M |
| Net Cash Flow From Investing Activities | -$476.56M |
| Net Cash Flow From Investing Activities, Continuing | -$476.56M |
| Net Cash Flow From Financing Activities | $418.84M |
| Net Cash Flow From Financing Activities, Continuing | $418.84M |
| Exchange Gains/Losses | $1.26M |
| Net Cash Flow | $67.03M |
| Net Cash Flow, Continuing | $65.77M |
| Comprehensive Income/Loss | $160.51M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $160.51M |
| Other Comprehensive Income/Loss | $160.51M |